tm logo

Monitor this mark

View On USPTO

FOSRENOL
Live/Registered
REGISTERED AND RENEWED

on 02 Sep 2023

Last Applicant/ Owned by

TAKEDA PHARMACEUTICALS U.S.A., INC.

500 Kendall Street

Cambridge

MA

02142

Serial Number

76118066 filed on 28th Aug 2000

Registration Number

2687871 registered on 18th Feb 2003

in the Principal Register

Correspondent Address

Karl M. Zielaznicki, Esq.

Karl M. Zielaznicki, Esq. Troutman Pepper Hamilton Sanders LLP

c/o IP Services NYC

New York, NY 10022

United States

Filing Basis

1. intent to use

Disclaimer

NO DATA

FOSRENOL

PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF HYPERPHOSPHATAEMIA, KIDNEY DISEASE AND DISORDERS [ AND OSTEOPOROSIS ]

Classification Information

Class [005]
Pharmaceutical Products

PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF HYPERPHOSPHATAEMIA, KIDNEY DISEASE AND DISORDERS [ AND OSTEOPOROSIS ]

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 76118066

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 250416000192

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
21st Nov 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
21st Nov 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
21st Nov 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21st Nov 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
21st Nov 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02th Sep 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02th Sep 2023REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
02th Sep 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02th Sep 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01st Mar 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP